Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;8(3):740-759.
doi: 10.1007/s13346-017-0429-9.

The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics

Affiliations
Review

The environmental pollutant, polychlorinated biphenyls, and cardiovascular disease: a potential target for antioxidant nanotherapeutics

Prachi Gupta et al. Drug Deliv Transl Res. 2018 Jun.

Abstract

Despite production having stopped in the 1970s, polychlorinated biphenyls (PCBs) represent persistent organic pollutants that continue to pose a serious human health risk. Exposure to PCBs has been linked to chronic inflammatory diseases, such as cardiovascular disease, type 2 diabetes, obesity, as well as hepatic disorders, endocrine dysfunction, neurological deficits, and many others. This is further complicated by the PCB's strong hydrophobicity, resulting in their ability to accumulate up the food chain and to be stored in fat deposits. This means that completely avoiding exposure is not possible, thus requiring the need to develop intervention strategies that can mitigate disease risks associated with exposure to PCBs. Currently, there is excitement in the use of nutritional compounds as a way of inhibiting the inflammation associated with PCBs, yet the suboptimal delivery and pharmacology of these compounds may not be sufficient in more acute exposures. In this review, we discuss the current state of knowledge of PCB toxicity and some of the antioxidant and anti-inflammatory nanocarrier systems that may be useful as an enhanced treatment modality for reducing PCB toxicity.

Keywords: Antioxidant; Nanocarriers; PCBs; Toxicity.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosure

All authors declare they have no conflicts of interest.

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Figure 4
Figure 4
Figure 5
Figure 5

Similar articles

Cited by

References

    1. Grimm FA, et al. Metabolism and metabolites of polychlorinated biphenyls. Crit Rev Toxicol. 2015;45(3):245–72. - PMC - PubMed
    1. Diamond ML, et al. Estimation of PCB stocks, emissions, and urban fate: will our policies reduce concentrations and exposure? Environ Sci Technol. 2010;44(8):2777–83. - PubMed
    1. Breivik K, et al. Towards a global historical emission inventory for selected PCB congeners--a mass balance approach. 2. Emissions. Sci Total Environ. 2002;290(1–3):199–224. - PubMed
    1. Giesy JP, Kannan K. Dioxin-like and non-dioxin-like toxic effects of polychlorinated biphenyls (PCBs): implications for risk assessment. Crit Rev Toxicol. 1998;28(6):511–69. - PubMed
    1. Salhotra AM. Human health risk assessment for contaminated properties. Prog Mol Biol Transl Sci. 2012;112:285–306. - PubMed

MeSH terms

LinkOut - more resources